The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNahl Group Regulatory News (NAH)

Share Price Information for Nahl Group (NAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.50
Bid: 66.00
Ask: 69.50
Change: 0.00 (0.00%)
Spread: 3.50 (5.303%)
Open: 67.50
High: 0.00
Low: 0.00
Prev. Close: 67.50
NAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

19 Mar 2019 11:20

RNS Number : 3180T
NAHL Group PLC
19 March 2019
 

19 March 2019

NAHL Group PLC

("NAHL" or the "Group")

Director/PDMR Shareholding

NAHL (AIM: NAH), the leading UK marketing and services business focused on the UK consumer legal market, was informed on 19 March 2019 by James Saralis (Group Chief Financial Officer) that he has today purchased 10,515 Ordinary Shares of £0.0025 in NAHL ("Ordinary Shares") at a price of 95.0 pence per share. Following this purchase Mr Saralis' interest in NAHL amounts to 27,181 ordinary shares representing 0.06 per cent of the issued share capital.

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

1.  

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

James Saralis

2.

Reason for the notification

a)

Position/status:

CFO

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

NAHL Group plc

b)

LEI:

213800FQN7XBX1S6U981

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of £0.0025 each

 

GB00BM7S2W63

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

95.0p

10,515

)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

 

e)

Date of the transaction:

19 March 2019

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

Enquiries:

 NAHL Group plc

Russell Atkinson (CEO)

James Saralis (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

finnCap Ltd (NOMAD & Broker)

Julian Blunt / James Thompson (Corporate Finance)

Andrew Burdis (Corporate Broking)

 

Tel: +44 (0) 20 7220 0500

FTI Consulting (Financial PR)

Alex Beagley

James Styles

 

Tel: +44 (0) 20 3727 1000

 Notes to Editors

NAHL Group plc is a leading UK marketing and services business focused on the UK consumer legal market. The Group comprises three divisions: Personal Injury (National Accident Helpline - NAH), Conveyancing (Fitzalan Partners - Fitzalan) and Critical Care (Bush & Company Rehabilitation - Bush). NAH provides outsourced marketing services in the personal injury market, Fitzalan, which includes Searches UK a leading conveyancing search provider, provides marketing services in the property market and Bush provides a range of specialist services in the catastrophic injury market.

More information is available at www.nahlgroupplc.co.uk and www.national-accident-helpline.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHJLMBTMBBBBPL
Date   Source Headline
23rd Apr 20247:00 amRNSNotice of Results and Investor Presentation
5th Apr 20241:51 pmRNSHolding(s) in Company
5th Apr 202412:19 pmRNSResponse to speculation
8th Mar 20247:00 amRNSRenewal of Banking Facilities
24th Jan 20247:00 amRNSYear End Trading Update
30th Oct 20237:00 amRNSGrant of options under SAYE Scheme
19th Oct 20236:07 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSNotice of Results and Investor Presentation
31st Jul 20235:00 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf Year Trading Update
2nd Jun 20235:24 pmRNSDirector/PDMR Shareholding
31st May 20235:00 pmRNSTotal Voting Rights
31st May 20233:50 pmRNSIssue of Equity and Total voting rights
25th May 20231:50 pmRNSHolding(s) in Company
25th May 20231:19 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement
19th May 20233:16 pmRNSIssue of Equity from Exercise of Share Options
18th May 20237:49 amRNSHolding(s) in Company
2nd May 202312:57 pmRNSGrant of Awards under Group Share Option Plan
28th Apr 20238:28 amRNSAnnual Report & Accounts and Notice of AGM
25th Apr 20237:00 amRNSSale of Homeward Legal
24th Apr 20232:43 pmRNSHolding(s) in Company
24th Mar 20234:59 pmRNSFinal Results – replacement
22nd Mar 20237:00 amRNSFinal Results
16th Mar 20237:00 amRNSNotice of Investor Presentation
24th Jan 20237:00 amRNSYear End Trading Update and Notice of Results
5th Dec 20222:42 pmRNSHolding(s) in Company
27th Sep 20227:00 amRNSInterim Results
22nd Sep 20227:00 amRNSNotice of Results and Investor Presentation
15th Sep 20227:00 amRNSDirectorate changes
2nd Aug 20221:15 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSHalf Year Trading Update
14th Jul 20221:58 pmRNSHolding(s) in Company
7th Jul 20224:44 pmRNSHoldings in Company
15th Jun 202212:13 pmRNSResult of AGM
15th Jun 20227:00 amRNSAGM Statement
10th May 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20227:00 amRNSGrant of Awards under Group Share Option Plan
29th Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSNotice of Investor Presentation
11th Feb 20227:00 amRNSChange of Nominated Adviser and Broker
19th Jan 20227:00 amRNSTrading Update and Revised Banking Facility
5th Jan 20225:02 pmRNSHolding(s) in Company
9th Dec 20217:00 amRNSIssue of Equity from Exercise of Share Options
14th Oct 20214:41 pmRNSSecond Price Monitoring Extn
14th Oct 20214:36 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
23rd Sep 20217:00 amRNSNotice of Investor Presentation
26th Aug 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.